- Home
- FF vs NKTX Comparison
FF vs NKTX Comparison
Compare FF & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FF
- NKTX
- Stock Information
- Founded
- FF N/A
- NKTX 2015
- Country
- FF United States
- NKTX United States
- Employees
- FF N/A
- NKTX N/A
- Industry
- FF Major Chemicals
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- FF Industrials
- NKTX Health Care
- Exchange
- FF Nasdaq
- NKTX Nasdaq
- Market Cap
- FF 172.1M
- NKTX 170.8M
- IPO Year
- FF N/A
- NKTX 2020
- Fundamental
- Price
- FF $3.94
- NKTX $1.81
- Analyst Decision
- FF Strong Buy
- NKTX Strong Buy
- Analyst Count
- FF 1
- NKTX 6
- Target Price
- FF $0.80
- NKTX $15.00
- AVG Volume (30 Days)
- FF 504.5K
- NKTX 2.5M
- Earning Date
- FF 05-08-2025
- NKTX 05-08-2025
- Dividend Yield
- FF 6.06%
- NKTX N/A
- EPS Growth
- FF N/A
- NKTX N/A
- EPS
- FF 0.35
- NKTX N/A
- Revenue
- FF $243,339,000.00
- NKTX N/A
- Revenue This Year
- FF N/A
- NKTX N/A
- Revenue Next Year
- FF N/A
- NKTX N/A
- P/E Ratio
- FF $11.26
- NKTX N/A
- Revenue Growth
- FF N/A
- NKTX N/A
- 52 Week Low
- FF $3.77
- NKTX $1.31
- 52 Week High
- FF $6.40
- NKTX $8.53
- Technical
- Relative Strength Index (RSI)
- FF 41.85
- NKTX 54.82
- Support Level
- FF $3.86
- NKTX $1.67
- Resistance Level
- FF $4.05
- NKTX $1.84
- Average True Range (ATR)
- FF 0.22
- NKTX 0.14
- MACD
- FF 0.01
- NKTX 0.03
- Stochastic Oscillator
- FF 30.91
- NKTX 68.42
About FF FutureFuel Corp. Common shares
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.